116 related articles for article (PubMed ID: 20615094)
1. Alanine-scanning mutations of the BMP-binding domain of recombinant secretory bovine spp24 affect cytokine binding.
Sun A; Murray SS; Simon RJ; Jawien J; Behnam K; Miller TA; Brochmann EJ
Connect Tissue Res; 2010 Dec; 51(6):445-51. PubMed ID: 20615094
[TBL] [Abstract][Full Text] [Related]
2. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
[TBL] [Abstract][Full Text] [Related]
3. Carboxy terminus of secreted phosphoprotein-24 kDa (spp24) is essential for full inhibition of BMP-2 activity.
Brochmann EJ; Simon RJ; Jawien J; Behnam K; Sintuu C; Wang JC; Murray SS
J Orthop Res; 2010 Sep; 28(9):1200-7. PubMed ID: 20162696
[TBL] [Abstract][Full Text] [Related]
4. Recombinant expression, isolation, and proteolysis of extracellular matrix-secreted phosphoprotein-24 kDa.
Murray EJ; Murray SS; Simon R; Behnam K
Connect Tissue Res; 2007; 48(6):292-9. PubMed ID: 18075815
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-2 activity is regulated by secreted phosphoprotein-24 kd, an extracellular pseudoreceptor, the gene for which maps to a region of the human genome important for bone quality.
Brochmann EJ; Behnam K; Murray SS
Metabolism; 2009 May; 58(5):644-50. PubMed ID: 19375587
[TBL] [Abstract][Full Text] [Related]
6. Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells.
Lee KB; Murray SS; Duarte ME; Spitz JF; Johnson JS; Song KJ; Brochmann EJ; Taghavi CE; Keorochana G; Liao JC; Wang JC
J Orthop Res; 2011 Nov; 29(11):1712-8. PubMed ID: 21509819
[TBL] [Abstract][Full Text] [Related]
7. Secreted phosphoprotein-24 kDa (Spp24) attenuates BMP-2-stimulated Smad 1/5 phosphorylation and alkaline phosphatase induction and was purified in a protective complex with alpha2 -Macroglobulins From Serum.
Zhao KW; Murray SS; Murray EJ
J Cell Biochem; 2013 Feb; 114(2):378-87. PubMed ID: 22949401
[TBL] [Abstract][Full Text] [Related]
8. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4.
Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T
Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215
[TBL] [Abstract][Full Text] [Related]
9. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors.
Lee NH; Geoghagen NS; Cheng E; Cline RT; Fraser CM
Mol Pharmacol; 1996 Jul; 50(1):140-8. PubMed ID: 8700106
[TBL] [Abstract][Full Text] [Related]
10. Alanine-scanning mutagenesis in the signature disulfide loop of the glycine receptor alpha 1 subunit: critical residues for activation and modulation.
Schofield CM; Trudell JR; Harrison NL
Biochemistry; 2004 Aug; 43(31):10058-63. PubMed ID: 15287733
[TBL] [Abstract][Full Text] [Related]
11. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
[TBL] [Abstract][Full Text] [Related]
12. BMP binding peptide: a BMP-2 enhancing factor deduced from the sequence of native bovine bone morphogenetic protein/non-collagenous protein.
Behnam K; Phillips ML; Silva JD; Brochmann EJ; Duarte ME; Murray SS
J Orthop Res; 2005 Jan; 23(1):175-80. PubMed ID: 15607890
[TBL] [Abstract][Full Text] [Related]
13. A carboxy terminal BMP/TGF-β binding site in secreted phosphoprotein 24 kD independently affects BMP-2 activity.
Tian H; Li CS; Zhao KW; Wang JC; Duarte ME; David CL; Phan K; Atti E; Brochmann EJ; Murray SS
J Cell Biochem; 2015 Apr; 116(4):667-76. PubMed ID: 25418420
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
15. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
16. Full-length spp24, but not its 18.5-kDa proteolytic fragment, inhibits bone-healing in a rodent model of spine fusion.
Sintuu C; Simon RJ; Miyazaki M; Morishita Y; Hymanson HJ; Taghavi C; Brochmann EJ; Murray SS; Wang JC
J Bone Joint Surg Am; 2011 Jun; 93(11):1022-32. PubMed ID: 21655895
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis, kinetic, and spectroscopic studies of the P-loop residues in a low molecular weight protein tyrosine phosphatase.
Evans B; Tishmack PA; Pokalsky C; Zhang M; Van Etten RL
Biochemistry; 1996 Oct; 35(42):13609-17. PubMed ID: 8885840
[TBL] [Abstract][Full Text] [Related]
18. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site.
Antikainen NM; Hergenrother PJ; Harris MM; Corbett W; Martin SF
Biochemistry; 2003 Feb; 42(6):1603-10. PubMed ID: 12578373
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.
Zhang JL; Qiu LY; Kotzsch A; Weidauer S; Patterson L; Hammerschmidt M; Sebald W; Mueller TD
Dev Cell; 2008 May; 14(5):739-50. PubMed ID: 18477456
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ligand-binding properties of the human BMP type II receptor extracellular domain.
Yin H; Yeh LC; Hinck AP; Lee JC
J Mol Biol; 2008 Apr; 378(1):191-203. PubMed ID: 18342887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
